世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

三次元細胞培養市場:製品毎(足場なし、ミクロ流体、磁気浮上)、用途毎(がん、幹細胞研究、創薬)、エンドユーザ毎技術毎、用途毎(がん細胞検査、細胞アッセイ・毒性スクリーニング)、エンドユーザ毎(医薬品産業、バイオテクノロジ、研究) - 2022年までの世界市場予測

3D Cell Culture Market by Product (Scaffold-free (Hanging Drop, Bioreactor), Microfluidics, Magnetic Levitation), Application (Cancer, Stem Cell Research, Drug Discovery), End User (Pharmaceutical, Biotech, Research) - Global Forecast to 2022

 

出版社 出版年月電子版価格 ページ数図表数
MarketsandMarkets
マーケッツアンドマーケッツ
2017年11月US$4,950
シングルユーザライセンス
139 145

サマリー

幅広い市場に関する調査レポートを出版しているマーケッツアンドマーケッツ(MarketsandMarkets)の三次元細胞培養市場に関する調査レポートです。

“Global 3D cell culture market projected to grow at a CAGR of 20.3%”

The 3D cell culture market is expected to reach USD 1,702.3 million by 2022 from USD 682.8 million in 2017, at a CAGR of 20.3%. The rising focus on developing alternative methods for animal testing, funding initiatives from government and private investors, technological advancements and product launches, and growing awareness are driving the growth of the 3D cell culture market. On the other hand, market growth may be limited to a certain extent due to the lack of infrastructure for 3D cell-based research.

“Scaffold-based 3D cell culture products are expected to grow at the highest CAGR during the forecast period”

By product, the 3D cell culture market is segmented into scaffold-based 3D cell culture, scaffold-free 3D cell culture, microfluidics-based 3D cell culture, and magnetic levitation and 3D bioprinting. The scaffold-based 3D cell culture products segment is projected to register the highest CAGR during the forecast period. The high growth in this segment is attributed to the ability of scaffold-based products to mimic in vivo conditions, thus driving their adoption among end users.

“Cancer and stem cell research segment is expected to dominate the market during the forecast period”

Based on the applications, the 3D cell culture market is segmented into cancer and stem cell research, drug discovery and toxicology testing, and tissue engineering and regenerative medicine. The cancer and stem cell research segment is expected to dominate the market during the forecast period. The increasing incidence of cancer and significant funding initiatives for cancer research from government as well as private organizations are supporting the growth of this application segment.

“Europe to witness high growth during the forecast period”

In 2017, North America is expected to account for the largest share of the market followed by Europe. However, Europe is expected to register the highest CAGR during the forecast period. The high growth in this regional segment is attributed to the growing prevalence of cancer, increasing venture capital investments, availability of technologically advanced products, strategic expansion of market players, and growing awareness of 3D cell culture through various conferences, symposia, workshops, and forums.

The primary interviews conducted for this report can be categorized as follows:

• By Company Type: Tier 1 – 25%; Tier 2 - 30%; Tier 3 - 45%.
• By Designation: C-level- 25%; D-level- 40%; others- 35%.
• By Region: North America-41%; Europe-30%; Asia-24%; RoW-5%.

List of companies profiled in the report

• Thermo Fisher (US
• Corning (US)
• Lonza (Switzerland)
• Merck (Germany)
• ReproCELL (Japan)
• InSphero (Switzerland)
• Global Cell Solutions (US)
• Synthecon (US)
• 3D Biotek (US)
• Kuraray (Japan)
• Hamilton Company (US)
• Mimetas (Netherlands)
• Emulate (US)
• Nano3D Biosciences (US)
• QGel (Switzerland)

Research Coverage:

The report provides an overview of the 3D cell culture market. It aims at estimating the market size and future growth potential of this market across different segments such as product, applications, end user, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market by providing them with the closest approximations of revenues for the overall 3D cell culture market and its subsegments. This report will help stakeholders to understand the competitive landscape better and gain insights to position their businesses and help companies make suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provide them with information regarding key market drivers and opportunities.
 



目次

1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.3 MARKET SCOPE 15
1.3.1 MARKETS COVERED 15
1.3.2 YEARS CONSIDERED FOR THE STUDY 15
1.4 CURRENCY 16
1.5 LIMITATIONS 16
1.6 MARKET STAKEHOLDERS 16
2 RESEARCH METHODOLOGY 17
2.1 RESEARCH DATA 17
2.2 SECONDARY DATA 18
2.2.1 SECONDARY SOURCES 18
2.3 PRIMARY DATA 19
2.3.1 PRIMARY SOURCES 19
2.3.2 INDUSTRY INSIGHTS 20
2.4 MARKET SIZE ESTIMATION 21
2.5 MARKET BREAKDOWN AND DATA TRIANGULATION 23
2.6 MARKET SHARE ESTIMATION 24
2.7 ASSUMPTIONS FOR THE STUDY 24
3 EXECUTIVE SUMMARY 25
4 PREMIUM INSIGHTS 29
4.1 GLOBAL 3D CELL CULTURE MARKET OVERVIEW 29
4.2 3D CELL CULTURE MARKET, BY PRODUCT 29
4.3 EUROPE: SCAFFOLD-FREE 3D CELL CULTURE MARKET, BY TYPE & COUNTRY 30
4.4 3D CELL CULTURE MARKET, BY APPLICATION 31
4.5 3D CELL CULTURE MARKET, BY END-USER 31
4.6 3D CELL CULTURE MARKET: GEOGRAPHIC SNAPSHOT 32

5 MARKET OVERVIEW 33
5.1 INTRODUCTION 33
5.2 MARKET DYNAMICS 33
5.2.1 MARKET DRIVERS 34
5.2.1.1 Focus on developing alternatives to animal testing 34
5.2.1.2 Availability of funding for research 34
5.2.1.3 Technological advancements and new product launches 35
5.2.1.4 Growing awareness 35
5.2.2 RESTRAINTS 36
5.2.2.1 Lack of infrastructure 36
5.2.3 OPPORTUNITIES 36
5.2.3.1 Emergence of microfluidics-based 3D cell culture 36
5.2.3.2 Regenerative medicine, an alternative to organ transplantation 36
5.2.4 CHALLENGES 37
5.2.4.1 Lack of consistency in 3D cell culture products 37
6 GLOBAL 3D CELL CULTURE MARKET, BY PRODUCT 38
6.1 INTRODUCTION 39
6.2 SCAFFOLD-BASED 3D CELL CULTURE 40
6.2.1 HYDROGELS/ECM ANALOGS 42
6.2.2 SOLID SCAFFOLDS 43
6.2.3 MICROPATTERNED SURFACES 45
6.3 SCAFFOLD-FREE 3D CELL CULTURE 46
6.3.1 LOW-ADHESION MICROPLATES 47
6.3.2 HANGING DROP PLATES 49
6.3.3 3D BIOREACTORS 50
6.3.4 3D PETRI DISHES 51
6.4 MICROFLUIDICS-BASED 3D CELL CULTURE 52
6.5 MAGNETIC LEVITATION & 3D BIOPRINTING 54
7 GLOBAL 3D CELL CULTURE MARKET, BY APPLICATION 56
7.1 INTRODUCTION 57
7.2 CANCER & STEM CELL RESEARCH 58
7.3 DRUG DISCOVERY & TOXICOLOGY TESTING 59
7.4 TISSUE ENGINEERING & REGENERATIVE MEDICINE 61
8 GLOBAL 3D CELL CULTURE MARKET, BY END-USER 63
8.1 INTRODUCTION 64
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 65
8.3 RESEARCH INSTITUTES 66

9 GLOBAL 3D CELL CULTURE MARKET, BY REGION 68
9.1 INTRODUCTION 69
9.2 NORTH AMERICA 70
9.2.1 US 73
9.2.2 CANADA 75
9.3 EUROPE 77
9.3.1 GERMANY 81
9.3.2 UK 83
9.3.3 FRANCE 85
9.3.4 ROE 87
9.4 APAC 89
9.5 ROW 92
10 COMPETITIVE LANDSCAPE 96
10.1 OVERVIEW 96
10.2 MARKET SHARE ANALYSIS 98
10.3 COMPETITIVE SITUATION AND TRENDS 100
10.3.1 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 100
10.3.2 PRODUCT LAUNCHES AND APPROVALS 101
10.3.3 EXPANSIONS 101
10.3.4 ACQUISITIONS 102
11 COMPANY PROFILES 103
(Business overview, Products offered, Recent Developments, SWOT analysis, MNM view)*
11.1 THERMO FISHER SCIENTIFIC 103
11.2 CORNING 106
11.3 MERCK 109
11.4 LONZA 112
11.5 REPROCELL 115
11.6 3D BIOTEK 118
11.7 EMULATE 119
11.8 GLOBAL CELL SOLUTIONS 120
11.9 HAMILTON 121
11.10 INSPHERO 122
11.11 KURARAY 124
11.12 MIMETAS 126
11.13 NANO3D BIOSCIENCES 127
11.14 SYNTHECON 128
11.15 QGEL 129
*Details on Business overview, Products offered, Recent Developments, SWOT analysis, MNM view might not be captured in case of unlisted companies.
12 APPENDIX 130
12.1 INSIGHTS FORM INDUSTRY EXPERTS 130
12.2 DISCUSSION GUIDE 131
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 133
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 135
12.5 AVAILABLE CUSTOMIZATIONS 136
12.6 RELATED REPORTS 136
12.7 AUTHOR DETAILS 137

 

LIST OF TABLES

TABLE 1 KEY PRODUCT LAUNCHES (2014-2017) 35
TABLE 2 RECENT CONFERENCES, WORKSHOPS, AND FORUMS FOR 3D CELL
CULTURE MARKET 35
TABLE 3 GLOBAL 3D CELL CULTURE MARKET, BY PRODUCT, 2015-2022, USD MILLION 39
TABLE 4 SCAFFOLD-BASED 3D CELL CULTURE MARKET, BY TYPE, 2015-2022,
USD MILLION 40
TABLE 5 SCAFFOLD-BASED 3D CELL CULTURE MARKET, BY REGION, 2015-2022,
USD MILLION 41
TABLE 6 NORTH AMERICA: SCAFFOLD-BASED 3D CELL CULTURE MARKET,  BY COUNTRY, 2015-2022 (USD MILLION) 41
TABLE 7 EUROPE: SCAFFOLD-BASED 3D CELL CULTURE MARKET, BY COUNTRY,  
2015-2022 (USD MILLION) 41
TABLE 8 HYDROGELS/ECM ANALOGS MARKET, BY REGION, 2015-2020, USD MILLION 42
TABLE 9 NORTH AMERICA: HYDROGELS/ECM ANALOGS MARKET, BY COUNTRY,  
2015-2022 (USD MILLION) 42
TABLE 10 EUROPE: HYDROGELS/ECM ANALOGS MARKET, BY COUNTRY,
2015-2022 (USD MILLION) 43
TABLE 11 SOLID SCAFFOLDS MARKET, BY REGION, 2015-2020, USD MILLION 44
TABLE 12 NORTH AMERICA: SOLID SCAFFOLDS MARKET, BY COUNTRY,
2015-2022 (USD MILLION) 44
TABLE 13 EUROPE: SOLID SCAFFOLDS MARKET, BY COUNTRY, 2015-2022 (USD MILLION) 44
TABLE 14 MICROPATTERNED SURFACES MARKET, BY REGION, 2015-2020, USD MILLION 45
TABLE 15 NORTH AMERICA: MICROPATTERNED SURFACES MARKET, BY COUNTRY,  
2015-2022 (USD MILLION) 45
TABLE 16 EUROPE: MICROPATTERNED SURFACES MARKET, BY COUNTRY,  
2015-2022 (USD MILLION) 46
TABLE 17 SCAFFOLD-FREE 3D CELL CULTURE MARKET, BY TYPE, 2015-2020, USD MILLION 47
TABLE 18 LOW-ADHESION MICROPLATES MARKET, BY REGION, 2015-2020, USD MILLION 48
TABLE 19 NORTH AMERICA: LOW-ADHESION MICROPLATES MARKET, BY COUNTRY,  
2015-2022 (USD MILLION) 48
TABLE 20 EUROPE: LOW-ADHESION MICROPLATES MARKET, BY COUNTRY,  
2015-2022 (USD MILLION) 48
TABLE 21 HANGING DROP PLATES MARKET, BY REGION, 2015-2020, USD MILLION 49
TABLE 22 NORTH AMERICA: HANGING DROP PLATES MARKET, BY COUNTRY,  
2015-2022 (USD MILLION) 49
TABLE 23 EUROPE: HANGING DROP PLATES MARKET, BY COUNTRY,
2015-2022 (USD MILLION) 50
TABLE 24 3D BIOREACTORS MARKET, BY REGION, 2015-2020, USD MILLION 50
TABLE 25 NORTH AMERICA: 3D BIOREACTORS MARKET, BY COUNTRY,
2015-2022 (USD MILLION) 51
TABLE 26 EUROPE: 3D BIOREACTORS MARKET, BY COUNTRY, 2015-2022 (USD MILLION) 51
TABLE 27 3D PETRI DISHES MARKET, BY REGION, 2015-2020, USD MILLION 51
TABLE 28 NORTH AMERICA: 3D PETRI DISHES MARKET, BY COUNTRY,
2015-2022 (USD MILLION) 52
TABLE 29 EUROPE: 3D PETRI DISHES MARKET, BY COUNTRY, 2015-2022 (USD MILLION) 52
TABLE 30 MICROFLUIDICS-BASED 3D CELL CULTURE MARKET, BY REGION,  
2015-2020, USD MILLION 53
TABLE 31 NORTH AMERICA: MICROFLUIDICS-BASED 3D CELL CULTURE MARKET,
BY COUNTRY, 2015-2022 (USD MILLION) 54
TABLE 32 EUROPE: MICROFLUIDICS-BASED 3D CELL CULTURE MARKET, BY COUNTRY,  2015-2022 (USD MILLION) 54
TABLE 33 MAGNETIC LEVITATION & 3D BIOPRINTING MARKET, BY REGION,
2015-2020, USD MILLION 55
TABLE 34 NORTH AMERICA: MAGNETIC LEVITATION & 3D BIOPRINTING MARKET,  
BY COUNTRY, 2015-2022 (USD MILLION) 55
TABLE 35 EUROPE: MAGNETIC LEVITATION & 3D BIOPRINTING MARKET, BY COUNTRY,  
2015-2022 (USD MILLION) 55
TABLE 36 GLOBAL 3D CELL CULTURE MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 57
TABLE 37 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH, BY REGION,  2015–2022 (USD MILLION) 58
TABLE 38 NORTH AMERICA: 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH,  BY COUNTRY, 2015–2022 (USD MILLION) 59
TABLE 39 EUROPE: 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH,  
BY COUNTRY, 2015–2022 (USD MILLION) 59
TABLE 40 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING,
BY REGION, 2015–2022 (USD MILLION) 60
TABLE 41 NORTH AMERICA: 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY COUNTRY, 2015–2022 (USD MILLION) 60
TABLE 42 EUROPE: 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING,  BY COUNTRY, 2015–2022 (USD MILLION) 60
TABLE 43 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE,  BY REGION, 2015–2022 (USD MILLION) 61
TABLE 44 NORTH AMERICA: 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2015–2022 (USD MILLION) 61
TABLE 45 EUROPE: 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2015–2022 (USD MILLION) 62
TABLE 46 GLOBAL 3D CELL CULTURE MARKET, BY END-USER, 2015–2022 (USD MILLION) 64
TABLE 47 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES,  BY REGION, 2015–2022 (USD MILLION) 65
TABLE 48 NORTH AMERICA: 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2015–2022 (USD MILLION) 65
TABLE 49 EUROPE: 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2015–2022 (USD MILLION) 66
TABLE 50 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY REGION,  
2015–2022 (USD MILLION) 67
TABLE 51 NORTH AMERICA: 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES,
BY COUNTRY, 2015–2022 (USD MILLION) 67
TABLE 52 EUROPE: 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY COUNTRY,  2015–2022 (USD MILLION) 67
TABLE 53 GLOBAL 3D CELL CULTURE MARKET, BY REGION, 2015–2022 (USD MILLION) 69
TABLE 54 NORTH AMERICA: 3D CELL CULTURE MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 71
TABLE 55 NORTH AMERICA: 3D CELL CULTURE MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 71
TABLE 56 NORTH AMERICA: SCAFFOLD-BASED 3D CELL CULTURE MARKET, BY TYPE,  
2015–2022 (USD MILLION) 71
TABLE 57 NORTH AMERICA: SCAFFOLD-FREE 3D CELL CULTURE MARKET, BY TYPE,  
2015–2022 (USD MILLION) 72
TABLE 58 NORTH AMERICA: 3D CELL CULTURE MARKET, BY APPLICATION,  
2015–2022 (USD MILLION) 72
TABLE 59 NORTH AMERICA: 3D CELL CULTURE MARKET, BY END-USER,
2015–2022 (USD MILLION) 72
TABLE 60 US: 3D CELL CULTURE MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 74
TABLE 61 US: SCAFFOLD-BASED 3D CELL CULTURE MARKET, BY TYPE,
2015–2022 (USD MILLION) 74
TABLE 62 US: SCAFFOLD-FREE 3D CELL CULTURE MARKET, BY TYPE,
2015–2022 (USD MILLION) 74
TABLE 63 US: 3D CELL CULTURE MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 75
TABLE 64 US: 3D CELL CULTURE MARKET, BY END-USER, 2015–2022 (USD MILLION) 75
TABLE 65 CANADA: 3D CELL CULTURE MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 76
TABLE 66 CANADA: SCAFFOLD-BASED 3D CELL CULTURE MARKET, BY TYPE,  
2015–2022 (USD MILLION) 76
TABLE 67 CANADA: SCAFFOLD-FREE 3D CELL CULTURE MARKET, BY TYPE,  
2015–2022 (USD MILLION) 76
TABLE 68 CANADA: 3D CELL CULTURE MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 77
TABLE 69 CANADA: 3D CELL CULTURE MARKET, BY END-USER, 2015–2022 (USD MILLION) 77
TABLE 70 EUROPE: 3D CELL CULTURE MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 79
TABLE 71 EUROPE: 3D CELL CULTURE MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 79
TABLE 72 EUROPE: SCAFFOLD-BASED 3D CELL CULTURE MARKET, BY TYPE,  
2015–2022 (USD MILLION) 79
TABLE 73 EUROPE: SCAFFOLD-FREE 3D CELL CULTURE MARKET, BY TYPE,  
2015–2022 (USD MILLION) 80
TABLE 74 EUROPE: 3D CELL CULTURE MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 80
TABLE 75 EUROPE: 3D CELL CULTURE MARKET, BY END-USER, 2015–2022 (USD MILLION) 80
TABLE 76 GERMANY: 3D CELL CULTURE MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 81
TABLE 77 GERMANY: SCAFFOLD-BASED 3D CELL CULTURE MARKET, BY TYPE,  
2015–2022 (USD MILLION) 81
TABLE 78 GERMANY: SCAFFOLD-FREE 3D CELL CULTURE MARKET, BY TYPE,  
2015–2022 (USD MILLION) 82
TABLE 79 GERMANY: 3D CELL CULTURE MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 82
TABLE 80 GERMANY: 3D CELL CULTURE MARKET, BY END-USER, 2015–2022 (USD MILLION) 82
TABLE 81 UK: 3D CELL CULTURE MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 83
TABLE 82 UK: SCAFFOLD-BASED 3D CELL CULTURE MARKET, BY TYPE,
2015–2022 (USD MILLION) 83
TABLE 83 UK: SCAFFOLD-FREE 3D CELL CULTURE 3D CELL CULTURE MARKET, BY TYPE,  2015–2022 (USD MILLION) 84
TABLE 84 UK: 3D CELL CULTURE MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 84
TABLE 85 UK: 3D CELL CULTURE MARKET, BY END-USER, 2015–2022 (USD MILLION) 84
TABLE 86 FRANCE: 3D CELL CULTURE MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 85
TABLE 87 FRANCE: SCAFFOLD-BASED 3D CELL CULTURE MARKET, BY TYPE,  
2015–2022 (USD MILLION) 85
TABLE 88 FRANCE: SCAFFOLD-FREE 3D CELL CULTURE 3D CELL CULTURE MARKET,
BY TYPE,  2015–2022 (USD MILLION) 86
TABLE 89 FRANCE: 3D CELL CULTURE MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 86
TABLE 90 FRANCE: 3D CELL CULTURE MARKET, BY END-USER, 2015–2022 (USD MILLION) 86
TABLE 91 ROE: 3D CELL CULTURE MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 87
TABLE 92 ROE: SCAFFOLD-BASED 3D CELL CULTURE MARKET, BY TYPE,
2015–2022 (USD MILLION) 87
TABLE 93 ROE: SCAFFOLD-FREE 3D CELL CULTURE 3D CELL CULTURE MARKET, BY TYPE,  2015–2022 (USD MILLION) 88
TABLE 94 ROE: 3D CELL CULTURE MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 88
TABLE 95 ROE: 3D CELL CULTURE MARKET, BY END-USER, 2015–2022 (USD MILLION) 88
TABLE 96 APAC: 3D CELL CULTURE MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 91
TABLE 97 APAC: SCAFFOLD-BASED 3D CELL CULTURE MARKET, BY TYPE,  
2015–2022 (USD MILLION) 91
TABLE 98 APAC: SCAFFOLD-FREE 3D CELL CULTURE 3D CELL CULTURE MARKET, BY TYPE,  2015–2022 (USD MILLION) 91
TABLE 99 APAC: 3D CELL CULTURE MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 92
TABLE 100 APAC: 3D CELL CULTURE MARKET, BY END-USER, 2015–2022 (USD MILLION) 92
TABLE 101 ROW: 3D CELL CULTURE MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 94
TABLE 102 ROW: SCAFFOLD-BASED 3D CELL CULTURE MARKET, BY TYPE,  
2015–2022 (USD MILLION) 94
TABLE 103 ROW: SCAFFOLD-FREE 3D CELL CULTURE 3D CELL CULTURE MARKET,  
BY TYPE, 2015–2022 (USD MILLION) 94
TABLE 104 ROW: 3D CELL CULTURE MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 95
TABLE 105 ROW: 3D CELL CULTURE MARKET, BY END-USER, 2015–2022 (USD MILLION) 95
TABLE 106 RECENT AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 100
TABLE 107 RECENT PRODUCT LAUNCH AND APPROVALS 101
TABLE 108 RECENT EXPANSIONS 101
TABLE 109 RECENT ACQUISITIONS 102
TABLE 110 EXCHANGE RATES (UTILIZED FOR CONVERSION OF EURO TO USD) 110
TABLE 111 EXCHANGE RATES (UTILIZED FOR CONVERSION OF CHF TO USD) 113

 

LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 17
FIGURE 2 BREAK DOWN OF PRIMARY INTERVIEWS: BY COMPANY, DESIGNATION,  
AND REGION 20
FIGURE 3 MARKET ESTIMATION: BOTTOM-UP APPROACH 21
FIGURE 4 GLOBAL MARKET SIZE OF 3D CEL CULTURE MARKET: TOP-DOWN APPROACH 22
FIGURE 5 DATA TRIANGULATION METHODODLOGY 23
FIGURE 6 SCAFFOLD-BASED 3D CELL CULTURE SEGMENT TO LEAD THE MARKET,
BY PRODUCT, 2017-2022 (USD MILION) 25
FIGURE 7 HYDROGELS/ECM ANALOGS SUB-SEGMENT TO WITNESS HIGHEST CAGR,  
2017-2022 (USD MILLION) 26
FIGURE 8 CANCER & STEM CELL RESEARCH SEGMENT TO LEAD GLOBAL 3D CELL CULTURE MARKET, BY APPLICATION, 2017-2022 (USD MILLION) 26
FIGURE 9 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT TO LEAD GLOBAL 3D CELL CULTURE MARKET, BY END-USER, 2017-2022 (USD MILLION) 27
FIGURE 10 EUROPE TO RECORD HIGHEST CAGR DURING THE FORECAST PERIOD 27
FIGURE 11 FOCUS ON DEVELOPING ALTERNATIVES TO ANIMAL TESTING TO DRIVE THE MARKET GROWTH 29
FIGURE 12 SCAFFOLD-BASED 3D CELL CULTURE SEGMENT TO LEAD THE MARKET,
2017-2022 (USD MILLION) 29
FIGURE 13 LOW-ADHESION MICROPLATES SUB-SEGMENT TO HOLD THE LARGEST SHARE 30
FIGURE 14 CANCER & STEM CELL RESEARCH SEGMENT TO WITNESS HIGH GROWTH,
2017-2022 (USD MILLION) 31
FIGURE 15 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT TO LEAD THE MARKET, 2017-2022 (USD MILLION) 31
FIGURE 16 GERMANY TO WITNESS HIGHEST CAGR DURING THE FORECAST PERIOD 32
FIGURE 17 3D CELL CULTURE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 33
FIGURE 18 SCAFFOLD-BASED 3D CELL CULTURE SEGMENT TO DOMINATE THE MARKET, 2017-2022 (USD MILLION) 39
FIGURE 19 HYDROGELS/ECM ANALOGS SUB-SEGMENT TO DOMINATE THE MARKET,  
2017-2022 (USD MILLION) 40
FIGURE 20 LOW-ADHESION MICROPLATES SUB-SEGMENT TO RECORD HIGHEST CAGR,
2017-2022 (USD MILLION) 46
FIGURE 21 CANCER & STEM CELL RESEARCH APPLICATION SEGMENT TO LEAD THE MARKET, 2017-2022 (USD MILLION) 57
FIGURE 22 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT TO LEAD GLOBAL 3D CELL CULTURE MARKET, 2017-2022 (USD MILLION) 64
FIGURE 23 NORTH AMERICA TO LEAD GLOBAL 3D CELL CULTURE MARKET,  
2017-2022 (USD MILLION) 69
FIGURE 24 NORTH AMERICA: 3D CELL CULTURE MARKET SNAPSHOT 70
FIGURE 25 EUROPE: 3D CELL CULTURE MARKET SNAPSHOT 78
FIGURE 26 APAC: 3D CELL CULTURE MARKET SNAPSHOT 90
FIGURE 27 ROW: 3D CELL CULTURE MARKET SNAPSHOT 93
FIGURE 28 MARKET EVOLUTION FRAMEWORK 97
FIGURE 29 3D CELL CULTURE MARKET SHARE ANALYSIS, BY KEY PLAYER (2016) 98
FIGURE 30 THERMO FISHER SCIENTIFIC, : COMPANY SNAPSHOT (2016) 103
FIGURE 31 CORNING: COMPANY SNAPSHOT (2016) 106
FIGURE 32 MERCK: COMPANY SNAPSHOT (2016) 109
FIGURE 33 LONZA: COMPANY SNAPSHOT (2016) 112
FIGURE 34 KURARAY: COMPANY OVERVIEW (2016) 124
 

 

ページTOPに戻る

プレスリリース

[プレスリリース原文]

3D Cell Culture Market worth 1,720.3 Million USD by 2022


November 8, 2017

The report "3D Cell Culture Market by Product (Scaffold-free (Hanging Drop, Bioreactor), Microfluidics, Magnetic Levitation), Application (Cancer, Stem Cell Research, Drug Discovery), End User (Pharmaceutical, Biotech, Research) - Global Forecast to 2022", The 3D cell culture market is expected to reach USD 1,720.3 Million by 2022 from USD 682.8 Million in 2017, at a CAGR of 20.3%. The growth of the market is attributed to the rising focus on developing alternative methods for animal testing, funding initiatives from government and private investors, technological advancements and product launches, and growing awareness.

Scaffold-based 3D cell culture products expected to dominate the market in 2017.

Based on product, the 3D cell culture market is segmented into scaffold-based 3D cell culture, scaffold-free 3D cell culture, microfluidics-based 3D cell culture, and magnetic levitation and 3D bioprinting. In 2017, the scaffold-based 3D cell culture products segment is expected to account for the largest share of the 3D cell culture market. The high growth in this segment is attributed to the ability of scaffold-based products to mimic in vivo conditions, thus driving their adoption among end users.

Based on applications, the cancer and stem cell research segment is projected to grow at the highest CAGR during the forecast period.

By applications, the 3D cell culture market is segmented into cancer and stem cell research, drug discovery and toxicology testing, and tissue engineering and regenerative medicine. The cancer and stem cell research segment is expected to register the highest CAGR during the forecast period. The increasing incidence of cancer and significant funding initiatives for cancer research from government as well as private organizations are supporting the growth of this application segment.

North America to dominate the 3D cell culture market

In 2017, North America is expected to dominate the market followed by Europe. The large share of this geographical segment is attributed to factors such as increasing incidence of cancer, presence of a well-established pharmaceutical and biotechnology industry, significant support from the government in the form of funds and grants, availability of technologically advanced products, and presence of key market players.

The 3D cell culture market is highly competitive with the presence of several small and big players. Some of the players in the 3D cell culture market include Thermo Fisher (US), Corning (US), Lonza (Switzerland), Merck (Germany), ReproCELL (Japan), and InSphero (Switzerland). The other players operating in this market include Global Cell Solutions (US), Synthecon (US), 3D Biotek (US), Kuraray (Japan), Hamilton Company (US), Mimetas (Netherlands), Emulate (US), Nano3D Biosciences (US), and QGel (Switzerland).

 

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る